174 related articles for article (PubMed ID: 12058885)
21. Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home.
Lee C; Loeb M; Phillips A; Nesbitt J; Smith K; Fearon M; McArthur MA; Mazzulli T; Li Y; McGeer A
Infect Control Hosp Epidemiol; 2000 Nov; 21(11):700-4. PubMed ID: 11089653
[TBL] [Abstract][Full Text] [Related]
22. Oseltamivir.
Bardsley-Elliot A; Noble S
Drugs; 1999 Nov; 58(5):851-60; discussion 861-2. PubMed ID: 10595865
[TBL] [Abstract][Full Text] [Related]
23. Summer influenza outbreak in a home for the elderly: application of preventive measures.
Gaillat J; Dennetière G; Raffin-Bru E; Valette M; Blanc MC
J Hosp Infect; 2008 Nov; 70(3):272-7. PubMed ID: 18799243
[TBL] [Abstract][Full Text] [Related]
24. [Control of hospital infection of influenza: administration of neuraminidase inhibitor and cohort isolation of influenza patients].
Kosugi Y; Ishikawa T; Chimura Y; Annaka M; Shibazaki S; Adachi K; Higuchi H; Shinkai T; Sadamasu K; Masuda Y; Inamatsu T
Kansenshogaku Zasshi; 2004 Dec; 78(12):995-9. PubMed ID: 15678974
[TBL] [Abstract][Full Text] [Related]
25. Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population.
Peters PH; Gravenstein S; Norwood P; De Bock V; Van Couter A; Gibbens M; von Planta TA; Ward P
J Am Geriatr Soc; 2001 Aug; 49(8):1025-31. PubMed ID: 11555062
[TBL] [Abstract][Full Text] [Related]
26. The use of oseltamivir during an influenza B outbreak in a chronic care hospital.
Seale H; Weston KM; Dwyer DE; Zhu M; Allchin L; Booy R; MacIntyre CR
Influenza Other Respir Viruses; 2009 Jan; 3(1):15-20. PubMed ID: 19453437
[TBL] [Abstract][Full Text] [Related]
27. [Neuraminidase inhibitor].
Kaji M
Nihon Rinsho; 2000 Nov; 58(11):2293-8. PubMed ID: 11225320
[TBL] [Abstract][Full Text] [Related]
28. Neuraminidase inhibitors for preventing and treating influenza in children.
Matheson NJ; Symmonds-Abrahams M; Sheikh A; Shepperd S; Harnden A
Cochrane Database Syst Rev; 2003; (3):CD002744. PubMed ID: 12917931
[TBL] [Abstract][Full Text] [Related]
29. Neuraminidase inhibitors for influenza.
Moscona A
N Engl J Med; 2005 Sep; 353(13):1363-73. PubMed ID: 16192481
[No Abstract] [Full Text] [Related]
30. [Practice guideline 'Influenza prevention in nursing homes and care homes', issued by the Dutch Society of Nursing Home Specialists; division of tasks between nursing home specialist, general practitioner and company doctor].
Cools HJ; van Essen GA;
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):119-24; discussion 116-8. PubMed ID: 15693586
[TBL] [Abstract][Full Text] [Related]
31. [A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population].
Lin JT; Yu XZ; Cui DJ; Chen XY; Zhu JH; Wang YZ; Wu XD; Gao H; Huo ZL; Zhu SH; Hu SL; Wang AX
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):455-9. PubMed ID: 15312558
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and dosage recommendations for an oseltamivir oral suspension for the treatment of influenza in children.
Oo C; Barrett J; Hill G; Mann J; Dorr A; Dutkowski R; Ward P
Paediatr Drugs; 2001; 3(3):229-36. PubMed ID: 11310719
[TBL] [Abstract][Full Text] [Related]
33. Neuraminidase inhibitors for treatment of influenza A and B infections.
MMWR Recomm Rep; 1999 Dec; 48(RR-14):1-9. PubMed ID: 10632443
[TBL] [Abstract][Full Text] [Related]
34. [A multicenter study of efficacy and safety of oseltamivir in the treatment of suspected influenza patients].
Deng WW; Li QY; Zhong NS;
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2132-6. PubMed ID: 15730636
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the use of oseltamivir prophylaxis in the control of influenza outbreaks in long-term care facilities in Alberta, Canada: a retrospective provincial database analysis.
Ye M; Jacobs A; Khan MN; Jaipaul J; Oda J; Johnson M; Doroshenko A
BMJ Open; 2016 Jul; 6(7):e011686. PubMed ID: 27381211
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza--placebo-controlled double-blind multicenter phase III trial].
Kashiwagi S; Kudoh S; Watanabe A; Yoshimura I
Kansenshogaku Zasshi; 2000 Dec; 74(12):1062-76. PubMed ID: 11193558
[TBL] [Abstract][Full Text] [Related]
37. Outbreaks of influenza-like illness in care homes in the East of England: impact of variations in neuraminidase inhibitor provision.
Yip JLY; Kapadia S; Ahmed A; Millership S
Public Health; 2018 Sep; 162():98-103. PubMed ID: 29990618
[TBL] [Abstract][Full Text] [Related]
38. Updated treatment for influenza A and B.
Montalto NJ; Gum KD; Ashley JV
Am Fam Physician; 2000 Dec; 62(11):2467-76. PubMed ID: 11130232
[TBL] [Abstract][Full Text] [Related]
39. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
[TBL] [Abstract][Full Text] [Related]
40. [Amantadine usage for influenza A during an influenza outbreak in a nursing home].
Ikematsu H; Nabeshima A; Yong C; Li W; Kajiyama W; Hara H; Hayashi J; Kashiwagi S
Kansenshogaku Zasshi; 2000 May; 74(5):476-80. PubMed ID: 10860361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
